U.S. Department of Commerce Invests $4.6 Million in FITCI
FITCI's [email protected] merges community, entrepreneurial spirit, and economic development in Frederick, MD
By EDA | August 30, 2022
U.S. Department of Commerce Invests $4.6 Million in American Rescue Plan Funds for Building Renovations to Support Job Growth in Frederick, MarylandWASHINGTON – Today, (4/31/22) U.S. Secretary of Commerce Gina Raimondo announced that the Department’s Economic Development Administration (EDA) is... Read more
Meridian BioGroup acquired by Pace® Life Sciences.
Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets
By Meridian BioGroup | August 24, 2022
We are excited to announce, that Meridian BioGroup has been acquired by Pace® Life Sciences. The acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated... Read more
A single injection hepatitis B cure attracts international attention
Dr. Yong-Yuan Zhang presents in Paris, Seoul, and Washington DC in 2022
By April Bartel | August 19, 2022
A single injection hepatitis B cure attracts international attention Frederick, MD – HBVtech, a biopharma startup company within the Frederick Innovation Technology Center (FITCI), is garnering international attention for its work creating a single-dose injection-based hepatitis B cure. ... Read more
Mesa Science Associates Receives Grant to Study Marfan Syndrome Treatment
Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies
By Mesa Associates, Inc. | July 15, 2022
Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of Health (NIH) entitled “Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies.”Upon receiving... Read more
AFFORDABLE POINT OF SERVICE HEALTHCARE ACCESS COMES TO MARYLANDERS
MARYLAND BUSINESSES PARTNERSHIP TO PROVIDE TELEHEALTH PLATFORM TO MITIGATE HEALTH INEQUITY
By Ashok Kapur, Hawkeye MedTech | July 19, 2022
Columbia, MD, July 18, 2022 - Hawkeye Med Tech, Inc, a Maryland Medtech company has partnered with the Kiosk Group, Ltd,. to produce one-of-a-kind Portable TotalCare Telehealth StationTM or PTTS. PTTS is a Made in Maryland integrated telehealth tablet, blood pressure machine and pulse oximeter. PTTS... Read more
FITCI Grad BioFactura Announces Activation of a $15.9M Contract Option
Smallpox Biodefense Therapeutic, contract valued at up to $68.2 million
By Darryl Sampey, Ph.D., CEO | July 15, 2022
FREDERICK, MARYLAND, JULY 14, 2022: BioFactura today announced its second contract option activation of $15.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to advance development of an antibody cocktail therapeutic for the treatment of smallpox. This funding is part... Read more
TEDCO Invests in FITCI Member, Alirtify, a Rural Maryland Pre-Seed Company
Alirtify is an intelligence-gathering platform
By Tammi Thomas, Chief Marketing & Communications Officer, TEDCO [email protected] | July 05, 2022
July 5, 2022—TEDCO, Maryland’s economic engine for technology companies (and a FITCI founding partner), announced today that its Rural Business Innovation Initiative (RBII) made a $25,000 investment in Alirtify, an intelligence-gathering platform based in Frederick, Md. “This new... Read more
Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion
Theradaptive's technology re-grows bone
By Serena Lertora [email protected] | June 22, 2022
FREDERICK, Md. and BOSTON, June 22, 2022 /PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation for the use of OsteoAdapt... Read more
Veralox Therapeutics Announces Favorable Results of Phase 1 Studies of VLX-1005
A novel small molecule 12-LOX inhibitor, awarded Fast Track designation by US Food and Drug Administration
By | June 13, 2022
for Treatment of Heparin-Induced ThrombocytopeniaFREDERICK, Md., June 13, 2022 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat serious immuno-inflammatory diseases with significant unmet medical needs, today announced... Read more
KnowledgeNet.ai Achieves SOC 2 Type II Compliance
KnowledgeNet.ai meets the highest information security standards following an independent audit
By James Alvord | June 06, 2022
FREDERICK MD, June 7, 2022 – KnowledgeNet.ai, a leader in collaboration intelligence and knowledge sharing platform, announces the successful completion of the System and Organization Controls (SOC) 2 Type II Audit. Created by the American Institute of Certified Public Accountants (AICPA), SOC... Read more
iyotee Secures $9.35 Million In Series A Funding and Launches KnowledgeNet.ai
New AI-Driven Network Collaboration App Revolutionizes How Organizations Use Their Intellectual Capital
By James Alvord | February 11, 2022
FREDERICK MD, February 09, 2022 – KnowledgeNet.ai, a leader in knowledge intelligence, announced today that it has raised a $9.35M Series A investment round through syndicate investors. KnowledgeNet.ai goes beyond relationship intelligence to combine relationship intelligence, knowledge... Read more
FITCI Receives 2022 Grant from Rural Maryland Council
The Rural Maryland Prosperity Investment Fund Grant Will Help Build an Agricultural Technology Lab
By FITCI | October 20, 2021
(Frederick, MD) Frederick Innovative Technology Center, Inc (FITCI) was awarded Rural Maryland Council’s Rural Maryland Prosperity Investment Fund Grant for 2022 for the Ag-Tech Lab project, part of FITCI’s new Innovation Center. The funding, along with help from collaborators and partners like... Read more
FITCI earns Rural Maryland Council Outstanding Rural Economic Development Award
For Outstanding Leadership and Public Service in Advocating Policy Solutions to Greatly Benefit Rural Communities.
By April Bartel | December 07, 2021
The Frederick Innovative Technology Center, Inc. (FITCI) was recently honored for Outstanding Rural Economic Development by the Rural Maryland Council (RMC). The award was presented as part of the 2021 Rural Summit held in Annapolis on December 1 and 2. The event’s theme was Redefining... Read more
FITCI helps fellow nonprofits by “Giving BACK”
Board and staff volunteer, sharing the spirit of gratitude and generosity
By April Bartel | December 07, 2021
If November sparks gratitude and December is devoted to giving, now is a perfect time to acknowledge the good while renewing the spirit of fellowship and community. In response, team members at the Frederick Innovative Technology Center, Inc. (FITCI), a nonprofit dedicated to facilitating... Read more
Mesa Green Pharma LLC. Receives Positive Feedback from FDA’s Center for...
Pilot Study Provides Positive Results for K9MGP Treatment Active Canine Seizures
By Michael Mesa | September 27, 2021
FREDERICK, Md. September 21,2021— Mr. Michael Mesa, CEO of Mesa Green Pharma (MGP) stated that “company representatives met with FDA’s Center for Veterinary Medicine (CVM) on September 9, 2021, to discuss the company’s development program for K9MGP.” MGP is developing K9MGP as a treatment... Read more
Nanobiofab Earns $1.1M Defense Health Agency SBIR Grant for AI-powered platform
Novel nanomaterials measure pressure and volatile chemical compounds
By April Bartel | September 19, 2021
Frederick, Maryland – Tao Treasures LLC DBA Nanobiofab, a minority woman-owned nanotech startup in the Frederick Innovative Technology Center, Inc. (FITCI), is helping medical mannequins tell doctors where it hurts. The company, which creates revolutionary million-scale nanomaterial used in ... Read more
Dr. Ruoting Yang in Molecular Psychiatry on biotypes for PTSD
NanoBioFab co-founder garners industry attention
By | July 01, 2021
Geneva Scientist Dr. Ruoting Yang first-authored a manuscript published in Molecular Psychiatry on biotypes for post-traumatic stress disorder (PTSD), the first of their kind of any psychological disorder. Dr. Yang is a Computational Biologist, specializing in artificial intelligence,... Read more
THERADAPTIVE: shaping the future of regenerative medicine at military treatment...
Advanced theraputic can mean the difference between amputation and limb preservation
By The Geneva Foundation | June 30, 2021
The Geneva Foundation released a case study highlighting their work with FITCI member, Theradaptive. Theradaptive is shaping the future of regenerative medicine with a new platform to deliver therapeutics that promote targeted native tissue repair. Their lead therapeutic, AMP2, is applied... Read more
Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer
By Veralox Therapeutics | June 23, 2021
FREDERICK, MD – June 23, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Michael S. Hanna, MD, FACC, as chief... Read more
Old Line Capital Invests in CarrTech
Columbia, Maryland, June 10, 2021
By April Bartel, FITCI | June 18, 2021
Old Line Capital Partners announced today that they have made a significant investment in CarrTech LLC, to extend product development, sales, and marketing of CarrTech’s innovative filter needle. “CarrTech’s FROG device (Filter Removal of Glass) saves lives, prevents injury, and saves... Read more
